Detalles de la búsqueda
1.
Covid-19 vaccine immunogenicity in people living with HIV-1
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-456258
2.
Decline of humoral responses against SARS-CoV-2 Spike in convalescent individuals
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-194639
3.
Humoral responses against BQ.1.1 elicited after breakthrough infection and SARS-CoV-2 mRNA vaccination
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22283723
4.
SARS-CoV-2 BA.4/5 Spike recognition and neutralization elicited after the third dose of mRNA vaccine
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22278386
5.
Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22275056
6.
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-428097
7.
A long interval between priming and boosting SARS-CoV-2 mRNA vaccine doses enhances B cell responses with limited impact on T cell immunity
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-502672
8.
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a sixteen-week interval between doses
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21263532
9.
A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-506622
10.
A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-435972
11.
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-473679
12.
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-473317
Resultados
1 -
12
de 12
1
Próxima >
>>